Status:
COMPLETED
Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%
Lead Sponsor:
Innovative Medical
Conditions:
Glaucoma
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
To compare the diurnal curves in patients using bimatoprost 0.03% versus travoprost 0.004% for the treatment of glaucoma or ocular hypertension.
Eligibility Criteria
Inclusion
- · Male or female \> 18 years of age
- Naive to treatment or washed off any ocular hypotensive agents
- Untreated IOP \>19 mm Hg
- Diagnosis of open-angle glaucoma or ocular hypertension
- Ability to provide informed consent and likely to complete study
Exclusion
- · Known contraindication to bimatoprost or travoprost, or any component of any study medication
- Uncontrolled systemic disease
- Active ocular disease other than glaucoma or ocular hypertension
- Required use of ocular medications other than the study medications during the study
- History of intraocular surgery within the last 3 months
- Prior discontinuation of any of the study medications for reasons related to efficacy or safety
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00347802
Last Update
June 1 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr. Noecker
Pittsburgh, Pennsylvania, United States, 15213